CELGENE Trademark

Trademark Overview


On Monday, May 19, 2003, a trademark application was filed for CELGENE with the United States Patent and Trademark Office. The USPTO has given the CELGENE trademark a serial number of 76515116. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, October 2, 2013. This trademark is owned by Celgene Corporation. The CELGENE trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith

[ manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others ]

biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical and clinical use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system

biochemical catalysts for use in medical research; biological preparations for medical purposes, namely, for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; [ enzyme preparations for industrial purposes; enzymes for industrial purposes; ] proteins for [ industrial and ] human consumption, namely, animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; [ chemical preparations used to protect crops in the agricultural and horticultural field; ] medicinal and biological preparations for medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system

research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods for others [ ; agrochemical product development for others ]
celgene

General Information


Serial Number76515116
Word MarkCELGENE
Filing DateMonday, May 19, 2003
Status800 - REGISTERED AND RENEWED
Status DateWednesday, October 2, 2013
Registration Number2888517
Registration DateTuesday, September 28, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 6, 2004

Trademark Statements


Goods and Serviceseducational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith
Goods and Services[ manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others ]
Goods and Servicesbiological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical and clinical use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system
Pseudo MarkCELL GENE
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesbiochemical catalysts for use in medical research; biological preparations for medical purposes, namely, for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; [ enzyme preparations for industrial purposes; enzymes for industrial purposes; ] proteins for [ industrial and ] human consumption, namely, animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; [ chemical preparations used to protect crops in the agricultural and horticultural field; ] medicinal and biological preparations for medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system
Goods and Servicesresearch in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods for others [ ; agrochemical product development for others ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, May 30, 2003
Primary Code001
First Use Anywhere DateWednesday, December 31, 1986
First Use In Commerce DateWednesday, December 31, 1986

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 30, 2003
Primary Code005
First Use Anywhere DateWednesday, December 31, 1986
First Use In Commerce DateWednesday, December 31, 1986

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateWednesday, October 2, 2013
Primary Code040
First Use Anywhere DateWednesday, December 31, 1986
First Use In Commerce DateWednesday, December 31, 1986

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code041
First Use Anywhere DateWednesday, December 31, 1986
First Use In Commerce DateWednesday, December 31, 1986

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 30, 2003
Primary Code042
First Use Anywhere DateWednesday, December 31, 1986
First Use In Commerce DateWednesday, December 31, 1986

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events


Event DateEvent Description
Friday, December 19, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 29, 2003ASSIGNED TO EXAMINER
Friday, December 12, 2003NON-FINAL ACTION MAILED
Friday, December 19, 2003TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 15, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 19, 2004PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, April 30, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 16, 2004NOTICE OF PUBLICATION
Tuesday, July 6, 2004PUBLISHED FOR OPPOSITION
Tuesday, September 28, 2004REGISTERED-PRINCIPAL REGISTER
Thursday, June 16, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 2, 2009TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 20, 2009CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 20, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, September 30, 2013TEAS SECTION 8 & 9 RECEIVED
Monday, September 30, 2013REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, October 2, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 2, 2013REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Wednesday, October 2, 2013REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Wednesday, October 2, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, October 2, 2013NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, October 3, 2013NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 20, 2020NOTICE OF SUIT
Thursday, September 10, 2020NOTICE OF SUIT
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 28, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 11, 2024TEAS SECTION 8 & 9 RECEIVED